Infigratinib phosphate is the phosphate salt form of infigratinib, a selective fibroblast growth factor receptor (FGFR) inhibitor used as a research tool in oncology and cell signaling studies. It is supplied as high-purity solid or as a ready-to-use DMSO solution, suitable for biochemical, cellular, and in vivo research applications.
- Selective FGFR inhibition for target validation and pathway studies.
- High purity (99.6%) suitable for sensitive assays.
- Available as solid or 10 mM solution in DMSO for flexible use.
- Molecular weight and formula provided for dosing and formulation calculations.
- Applicable to in vitro cellular assays and in vivo pharmacology studies.
- Provided with accompanying safety and technical documentation.